Adaptive Biotechnologies Corporation
ADPT | NASDAQ
$28.28
+$0.42 (+1.51%)
Sep 22, 2026, 2:24 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -39.94M | -20.02M | -13.58M | 9.55M | -25.59M | -29.85M | -33.72M | -32.07M | -46.22M | -47.51M | -69.44M | -50.3M | -47.81M | -57.7M | -40.13M | -45.28M | -52.05M | -62.74M | -61.43M | -56M | -49.3M | -40.64M |
Depreciation & Amortization | 3.27M | 3.84M | 4.2M | 4.41M | 4.5M | 4.73M | 4.45M | 4.59M | 5M | 5.21M | 5.39M | 7.62M | 7.48M | 7.23M | 7.09M | 7.21M | 7M | 6.85M | 6.62M | 3.53M | 4.66M | 2.67M |
Stock-Based Compensation | 11.12M | 11.93M | 12.72M | n/a | 13.36M | n/a | 12.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.64M | n/a | 8.48M |
Other Working Capital | 637K | 482K | 3.1M | -37.88M | -7.97M | -4.88M | 570K | -9.46M | -3.17M | -3.42M | -6.06M | -15.9M | -6.94M | -11.08M | -10.53M | -22.15M | -16.33M | -7.82M | -9.27M | -11.59M | -15.06M | -12.27M |
Other Non-Cash Items | 18.14M | 1.01M | 1.17M | 12.79M | 607K | 12.78M | 893K | 13.44M | 21.09M | 14.25M | 40.63M | 14.64M | 16.32M | 15.79M | 13.5M | 15.04M | 17.46M | 13.64M | 13.16M | 3.55M | 13.32M | 3.83M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.01M | -6.3M | -2.45M | -33.87M | -5.31M | -16.14M | 3.05M | -13.03M | 2.83M | -10.31M | -3.51M | -18.65M | 449K | -24.48M | -10.48M | -19.37M | -19.48M | -22.21M | -12.17M | -6.17M | -5.89M | -32.59M |
Operating Cash Flow | -6.4M | -9.54M | 2.06M | -7.13M | -12.43M | -28.48M | -12.49M | -27.07M | -17.3M | -38.35M | -26.93M | -46.68M | -23.56M | -59.15M | -30.02M | -42.41M | -47.07M | -64.45M | -53.83M | -43.44M | -37.21M | -58.25M |
Capital Expenditures | -1.18M | -796K | -636K | -409K | -655K | -1.26M | -80K | -344K | -1.73M | -1.51M | -1.3M | -2.78M | -3.7M | -2.92M | -2.54M | -5.43M | -5.3M | -3.08M | -9.25M | -14.62M | -22.04M | -15.84M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -82.73M | -38.86M | -46.73M | -33.19M | -51.14M | -50.65M | -44.8M | -63.26M | -82.72M | -53.48M | -122M | -119.08M | -99.38M | -89.1M | -165.03M | -28.55M | -24.96M | -60.24M | -78.54M | -141.65M | -81.01M | -15.34M |
Sales Maturities Of Investments | 40.43M | 48.8M | 39.12M | 50.88M | 55.14M | 77.49M | 67M | 68.89M | 90.33M | 99.5M | 126.5M | 148M | 140.4M | 155M | 70.03M | 92M | 35M | 101M | 155M | 135M | 144.5M | 125M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -43.48M | 9.14M | -8.25M | 17.28M | 3.35M | 25.57M | 22.12M | 5.29M | 5.88M | 44.51M | 3.21M | 26.14M | 37.32M | 62.98M | -97.54M | 58.02M | 4.75M | 37.69M | 67.21M | -21.27M | 41.45M | 93.82M |
Debt Repayment | 160.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -316K | 124.69M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.39M | n/a | 12.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.36M | n/a | 14.19M |
Financial Cash Flow | 142.19M | 7.5M | 21.66M | 1.68M | 1.61M | 5.45M | 127K | 40K | 30K | 44K | 87K | 17K | 1.47M | 672K | 6K | 125.52M | 3.99M | 2.75M | 3.28M | 2.93M | 6.33M | 14.61M |
Net Cash Flow | 92.31M | 7.11M | 15.46M | 11.87M | -7.47M | 2.73M | 9.76M | -21.74M | -11.41M | 6.17M | -23.65M | -20.53M | 14.63M | 4.5M | -127.52M | 141.14M | -38.39M | -24.26M | 16.66M | -61.79M | 10.56M | 50.19M |
Free Cash Flow | -7.58M | -10.33M | 1.42M | -7.54M | -13.09M | -29.74M | -12.57M | -27.41M | -19.03M | -39.86M | -28.23M | -49.46M | -27.25M | -62.08M | -32.56M | -47.84M | -52.36M | -67.53M | -63.07M | -58.06M | -59.25M | -74.09M |
Adj. Free Cash Flow | -18.7M | -22.26M | -11.3M | -7.54M | -26.44M | -29.74M | -25.4M | -27.41M | -19.03M | -39.86M | -28.23M | -49.46M | -27.25M | -62.08M | -32.56M | -47.84M | -52.36M | -67.53M | -63.07M | -69.71M | -59.25M | -82.57M |
Maintenance CapEx | -1.18M | -796K | n/a | n/a | n/a | n/a | n/a | n/a | -1.73M | n/a | -1.3M | -2.78M | n/a | -2.92M | n/a | n/a | -540.45K | -2.91M | -1.98M | -2.26M | -5.6M | n/a |
Growth CapEx | n/a | n/a | -636K | -409K | -655K | -1.26M | -80K | -344K | n/a | -1.51M | n/a | n/a | -3.7M | n/a | -2.54M | -5.43M | -4.76M | -164.28K | -7.27M | -12.36M | -16.44M | -15.84M |
Owner Earnings | -7.58M | -10.33M | 2.06M | -7.13M | -12.43M | -28.48M | -12.49M | -27.07M | -19.03M | -38.35M | -28.23M | -49.46M | -23.56M | -62.08M | -30.02M | -42.41M | -47.61M | -67.37M | -55.8M | -45.7M | -42.81M | -58.25M |
Add to Watchlist
Select watchlists to add or remove ADPT